Path: ...!weretis.net!feeder6.news.weretis.net!4.us.feeder.erje.net!2.eu.feeder.erje.net!feeder.erje.net!newsfeed.xs4all.nl!newsfeed7.news.xs4all.nl!feeder.usenetexpress.com!tr2.eu1.usenetexpress.com!feeder1.feed.usenet.farm!feed.usenet.farm!news.uzoreto.com!news.muarf.org!nntpfeed.proxad.net!proxad.net!feeder1-1.proxad.net!cleanfeed1-a.proxad.net!nnrp1-2.free.fr!not-for-mail From: yves Subject: Re: Encore une =?iso-8859-1?B?6XR1ZGU=?= positive sur la vitamine D contre le covid-19 Newsgroups: fr.bio.medecine,fr.sci.biologie References: <5f6506f7$0$16182$426a74cc@news.free.fr> <5f651b81$0$24261$426a34cc@news.free.fr> User-Agent: Pan/0.144 (Time is the enemy; 28ab3ba git.gnome.org/pan2) MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Date: 18 Sep 2020 21:06:59 GMT Lines: 13 Message-ID: <5f652173$0$24259$426a74cc@news.free.fr> Organization: Guest of ProXad - France NNTP-Posting-Date: 18 Sep 2020 23:06:59 CEST NNTP-Posting-Host: 77.153.161.244 X-Trace: 1600463219 news-1.free.fr 24259 77.153.161.244:53250 X-Complaints-To: abuse@proxad.net Bytes: 1526 Le Fri, 18 Sep 2020 20:41:37 +0000, yves a écrit: > en double aveugle. ah non, elle est "double-masked" mais pas "double-blind placebo controlled". Je ne connais pas assez les méthodologies pour bien comprendre ce que la différence implique. @+ -- Yves